GTBP GT BIOPHARMA INC Product Launches 8-K Filing 2024 - Clinical Trial Agreement GT Biopharma Inc has entered into a $2 million agreement with the University of Minnesota to sponsor a phase 1 clinical trial for a new treatment targeting certain blood cancers over three years.Get access to all SEC 8-K filings of the GT BIOPHARMA INC